1. Share Prices

  2. Gsk PLC (GSK)

1,612.50p-31.00 (-1.89%)16 Apr 2024, 13:24
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Gsk PLC Fundamentals

Company NameGsk PLCLast Updated2024-04-16
IndustryDrug Manufacturers - GeneralSectorHealthcare
Shares in Issue4.086 bnMarket Cap£65.91 bn
PE Ratio13.71Dividend per Share£0.56
Dividend Yield3.53Dividend Cover2.15
EPS£1.20EPS Growth (%)0.14
PEG1.10DPS Growth (%)-0.2689
Debt Ratio0.3054Debt Equity Ratio1.1392
Asset Equity Ratio4.6116Cash Equity Ratio0.3902
Quick Ratio0.5438Current Ratio0.88
Price To Book Value5.0302ROCE0

Gsk PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total
Prelim2024-02-222024-04-11GBP0.1600
Interim2023-11-162024-01-11GBP0.1400
Interim2023-08-172023-10-12GBP0.1400
Interim2023-05-182023-07-13GBP0.1400
Prelim2023-02-232023-04-13GBP0.1375
Interim2022-11-172023-01-12GBP0.1375
Interim2022-08-182022-10-06GBP0.1625
Interim2022-05-192022-07-01GBP0.1750
Prelim2022-02-242022-04-07GBP0.2875
Interim2021-11-182022-01-13GBP0.2375
Interim2021-08-192021-10-07GBP0.2375
Interim2021-05-202021-07-08GBP0.2375

Gsk PLC Company Financials

Assets202320222021
Tangible Assets£9.96 bn£9.62 bn£10.67 bn
Intangible Assets£21.58 bn£21.36 bn£40.63 bn
Investments£1.22 bn£1.57 bn£2.21 bn
Total Fixed Assets£40.36 bn£39.38 bn£60.43 bn
Stocks£5.50 bn£5.15 bn£5.78 bn
Debtors£6.46 bn£6.22 bn£7.54 bn
Cash & Equivalents£4.99 bn£7.68 bn£4.13 bn
Other Assets£7.61 bn£6.82 bn£6.91 bn
Total Assets£59.01 bn£60.15 bn£79.10 bn
Liabilities202320222021
Creditors within 1 year£21.07 bn£22.81 bn£23.67 bn
Creditors after 1 year£25.14 bn£27.24 bn£34.09 bn
Other Liabilities000
Total Liabilities£46.21 bn£50.05 bn£57.76 bn
Net assets£12.79 bn£10.10 bn£21.34 bn
Equity202320222021
Called up share capital£1.35 bn£1.35 bn£1.35 bn
Share Premium£3.45 bn£3.44 bn£3.30 bn
Profit / Loss£6.06 bn£5.63 bn£3.60 bn
Other Equity£13.35 bn£10.60 bn£15.05 bn
Preference & Minorities-£552.00 m-£502.00 m£6.29 bn
Total Capital Employed£12.79 bn£10.10 bn£21.34 bn
Ratios202320222021
Debt Ratio£0.53£0.62£0.58
Debt-to-Equity£1.14£1.61£1.37
Assets / Equity4.61164.61164.6116
Cash / Equity0.39020.39020.3902
EPS£1.33£1.17£0.96
Cash Flow202320222021
Cash from operating activities£6.77 bn£7.40 bn£7.95 bn
Cashflow before financing£1.13 bn£8.23 bn£363.00 m
Increase in Cash-£468.00 m-£546.00 m-£1.41 bn
Income202320222021
Turnover£30.33 bn£29.32 bn£24.70 bn
Cost of sales£8.56 bn£9.55 bn£8.16 bn
Gross Profit£21.76 bn£19.77 bn£16.53 bn
Operating Profit£6.75 bn£6.43 bn£4.36 bn
Pre-Tax profit£6.06 bn£5.63 bn£3.60 bn

Gsk PLC Company Background

SectorHealthcare
ActivitiesIn the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Latest Interim Date26 Jul 2023
Latest Fiscal Year End Date31 Jan 2024

Gsk PLC Directors

AppointedNamePosition
2017-03-14Sir Deryck MaughanNon-Executive Director
2009-04-01Sir Ian Maurice Gray ProsserNon-Executive Director
2012-04-02Mr. James R. MurdochNon-Executive Director
2011-08-09Dr. Jean-Pierre Garnier, PhDExecutive Director,Chief Executive Officer
2023-03-10Ms. Lynn Laverty ElsenhansNon-Executive Director
2017-03-14Dr. Stephanie A. BurnsNon-Executive Director
2024-03-22Dr. Hal V BarronNon-Executive Director
2024-03-01Ms. Judy C. LewentNon-Executive Director
2023-03-10Dr. Laurie H. GlimcherNon-Executive Director
2015-05-07Sir Christopher Charles GentNon-Executive Director,Chairman
2018-03-13Sir Andrew P. WittyExecutive Director,Chief Executive Officer
2008-08-04Mr. Chris ViehbacherExecutive Director
2013-05-03Sir Crispin H. DavisNon-Executive Director
2017-03-14Dr. Daniel Podolsky, M.D.Non-Executive Director
2017-03-14Mr. Gerardus Johannes Wijers Non-Executive Director
2024-03-22Sir Jonathan Richard Symonds CBENon-Executive Director,Chairman
2011-10-20Mr. Julian HeslopExecutive Director,Chief Financial Officer
2012-09-28Mr. Lawrence CulpNon-Executive Director
2023-03-10Mr. Manvinder Singh BangaNon-Executive Director,Senior Independent Director
2018-03-13Dr. Moncef M. Slaoui, PhDChairman, Global R&D and Vaccines
2022-03-04Sir Philip Roy Hampton KBNon-Executive Director,Chairman
2015-05-07Mr. Tom De SwaanNon-Executive Director
2024-03-22Mr. Urs RohnerNon-Executive Director
2024-03-01Dame Vivienne Cox CBENon-Executive Director
2014-07-23Sir Robert Peter WilsonNon-Executive Director
2018-05-04Professor Sir. Roy AndersonNon-Executive Director
2024-03-22Mr. Charles A. BancroftNon-Executive Director,Senior Independent Director
2017-03-15Ms. Stacey CartwrightNon-Executive Director
2016-03-17Dr. Ronaldo Hermann SchmitzNon-Executive Director
2023-02-14Mrs. Victoria Anne WhyteCompany Secretary
2024-03-22Ms. Wendy BeckerNon-Executive Director
2024-03-22Dr. Vishal SikkaNon-Executive Director
2024-03-01Mr. Iain James MackayExecutive Director,Chief Financial Officer
2020-03-06Mr. Simon P Dingemans Executive Director,Chief Financial Officer
2018-03-28Mr. Patrick VallanceExecutive Director
2024-03-13Ms. Emma N. WalmsleyExecutive Director,Chief Executive Officer
2015-05-07Ms. Jing UlrichNon-Executive Director
2024-03-13Ms. Julie BrownExecutive Director,Chief Financial Officer
2024-03-22Dr. Jesse Goodman, M.D.,M.P.H.Non-Executive Director
2024-03-22Ms. Elizabeth McKee AndersonNon-Executive Director
2024-03-22Dr. Anne BealNon-Executive Director
2024-03-22Dr. Harry C DietzNon-Executive Director

Gsk PLC Contact Details

Company NameGSK PLC
Address980 Great West Road, Brentford, TW8 9GS
Telephone+44 2080475000
Websitehttps://www.gsk.com

Gsk PLC Advisors

AuditorDeloitte LLP
Phone+44 2079363000
Fax+44 2075831198
Financial PR AdviserBrunswick Group LLP
Phone+44 2074045959
Fax+44 2078312823
SolicitorAllen & Overy LLP
Phone+44 2030880000
Fax+44 207339999
BankNational Westminster Bank PLC
RegistrarEquiniti Limited
Remuneration ConsultantWillis Towers Watson
Phone+44 2071702000
Fax+44 2071702222
SolicitorSlaughter and May
Phone+44 2076001200
Fax+44 2070905000
BankHSBC Bank PLC
StockbrokerCiti
Phone+44 2079864000
Fax+44 2079862266
AuditorPricewaterhouseCoopers LLP
Phone+44 2075835000
Fax+44 2078224652
SolicitorCleary Gottlieb Steen & Hamilton
Phone+1 212 225-2000
Fax+1 212 225-3999
AuditorCoopers & Lybrand
AuditorDeloitte

Receive our
daily news email

Subscribe to the latest investing news by entering your email address below

You can opt out at any time.

For five days a week you will get

  • The latest company news
  • Insight into investment trends
  • Round-up of director's buys and sells
  • Articles from Shares magazine
Sharesmagazine cover

Plus more useful investment content and occasional promotional offers.

Shares Magazine Latest Issue Cover
Latest Issue:
11 Apr 2024Subscribe now

Market Overview

UK 350 Risers and Fallers

Risers

CompanyPrice% Chg
Savills PLC1,064.003.70
Croda International PLC4,870.002.12
Plus500 LTD2,014.001.77
Centamin PLC128.501.74
Centrica PLC132.301.38
Severn Trent PLC2,411.001.30

Fallers

CompanyPrice% Chg
Dr. Martens PLC64.73-31.83
Auction Technology Group PLC548.00-12.04
Qinetiq Group PLC335.20-6.32
Tui AG583.21-5.01
Hays PLC88.33-4.51
Ferrexpo PLC45.25-4.33